Aged just 27 when she was diagnosed with stage 4 bowel cancer, Taylor chats to Stephanie about the challenges of losing her identity to cancer, the pressure it put on her loved ones, and how accessing a clinical trial was literally "life-saving"!

“Without this treatment I would not be here. Immunotherapy as a cancer treatment is the way of the future. It should be the gold standard. It should be the frontline treatment for all cancer patients moving forward.” - Taylor

Taylor discusses the difficulties she faced as an early-onset bowel cancer patient living regionally, as well as the barriers associated with accessing a clinical trial, and the importance of this treatment being listed on the Pharmaceutical Benefits Scheme (PBS).